Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited)

v2.4.0.8
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) (USD $)
In Thousands, except Share data, unless otherwise specified
 3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Operating Expenses:        
Research and Development $ 866 $ 950 $ 2,722 $ 2,936
General and Administrative 353 55 1,417 159
Total operating expenses 1,219 1,005 4,139 3,095
Loss from operations (1,219) (1,005) (4,139) (3,095)
Interest income 50    50 2
Realized gain on sale of marketable securities       480   
Other expense (4)    (5)   
Fair value of warrant liabilities in excess of proceeds from financing       (946)   
Loss on return of escrowed shares, net (584)    (584)   
Change in fair value of derivative liabilities (792)    6,952   
Total other income (expense), net (1,330)    5,947 2
Income (loss) before income taxes (2,549) (1,005) 1,808 (3,093)
Income taxes            
Net income (loss) (2,549) (1,005) 1,808 (3,093)
Comprehensive income (loss):        
Net income (loss) (2,549) (1,005) 1,808 (3,093)
Unrealized loss on marketable securities 408    2,235   
Total comprehensive loss $ (2,141) $ (1,005) $ 4,043 $ (3,093)
Net income (loss) per common share:        
Net income (loss) per share, basic $ (0.01) $ (0.02) $ 0.01 $ (0.05)
Net loss per share, diluted $ (0.01) $ (0.02) $ (0.02) $ (0.05)
Weighed average common shares outstanding, basic and diluted 327,209 57,255 326,534 57,255